Helius Medical regains full Nasdaq compliance; subject to one-year monitor

Solana Co

Received Nasdaq notification on July 7, 2025 confirming compliance with $2.5M stockholders' equity requirement.
Regained Minimum Bid Price compliance on June 3, 2025; now meets all continued listing criteria.
Subject to Mandatory Panel Monitor until July 7, 2026; any future equity deficiency triggers delist process.
Previous hearing panel granted continuance contingent on meeting both requirements by June 30, 2025.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.